Glibenclamide for the Treatment of Acute CNS Injury

First introduced into clinical practice in 1969, glibenclamide (US adopted name, glyburide) is known best for its use in the treatment of diabetes mellitus type 2, where it is used to promote the release of insulin by blocking pancreatic K(ATP) [sulfonylurea receptor 1 (Sur1)-Kir6.2] channels. Durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurland, David B., Tosun, Cigdem, Pampori, Adam, Karimy, Jason K., Caffes, Nicholas M., Gerzanich, Volodymyr, Simard, J. Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817601/
https://www.ncbi.nlm.nih.gov/pubmed/24275850
http://dx.doi.org/10.3390/ph6101287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817601/
https://www.ncbi.nlm.nih.gov/pubmed/24275850
http://dx.doi.org/10.3390/ph6101287

Ejemplares similares